HIV and the menopause

Maria D. Fan, Bat Sheva Maslow, Nanette Santoro, Ellie Schoenbaum

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Dramatic improvement in the survival of the HIV population has occurred with the ascendance of highly active antiretroviral therapy (HAART). In the foreseeable future, HIV-infected women who acquired disease during the peak years of the epidemic are expected to survive to experience menopause and even years beyond. The HIV epidemic may be viewed as 'mature', as its earlier victims become part of the geriatric population. Research about the process of menopause in HIV-infected women and, conversely, about HIV infection in women undergoing menopause is currently limited. Existing research suggests that the process of menopause is affected by HIV infection, inasmuch as infected women appear to experience menopause at an earlier age, with greater symptomatology, and with different reproductive hormone profiles compared with HIV-uninfected women. HIV infection also appears to affect bone mineral density, cardiovascular disease and cognition, with some age-related interactions. Lifestyle and demographic factors have pervasive importance for both HIV infection and the menopause in women. This article reviews the current state of knowledge about the menopausal process in HIV-infected women, and the common conditions in postmenopausal women that are likely to be affected by HIV infection. Clinicians should appreciate the potential role of HIV infection in caring for menopause-aged women.

Original languageEnglish (US)
Pages (from-to)163-168
Number of pages6
JournalMenopause international
Volume14
Issue number4
DOIs
StatePublished - Dec 2008

Fingerprint

Menopause
HIV
HIV Infections
Highly Active Antiretroviral Therapy
Research
Geriatrics
Bone Density
Cognition
Population
Life Style
Cardiovascular Diseases
Demography
Hormones
Survival

Keywords

  • Bone density
  • Cardiovascular diseases
  • Cognition
  • HIV
  • Menopause

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Medicine(all)

Cite this

Fan, M. D., Maslow, B. S., Santoro, N., & Schoenbaum, E. (2008). HIV and the menopause. Menopause international, 14(4), 163-168. https://doi.org/10.1258/mi.2008.008027

HIV and the menopause. / Fan, Maria D.; Maslow, Bat Sheva; Santoro, Nanette; Schoenbaum, Ellie.

In: Menopause international, Vol. 14, No. 4, 12.2008, p. 163-168.

Research output: Contribution to journalArticle

Fan, MD, Maslow, BS, Santoro, N & Schoenbaum, E 2008, 'HIV and the menopause', Menopause international, vol. 14, no. 4, pp. 163-168. https://doi.org/10.1258/mi.2008.008027
Fan, Maria D. ; Maslow, Bat Sheva ; Santoro, Nanette ; Schoenbaum, Ellie. / HIV and the menopause. In: Menopause international. 2008 ; Vol. 14, No. 4. pp. 163-168.
@article{015813fc50ef4fefa1447dfb6eb3972b,
title = "HIV and the menopause",
abstract = "Dramatic improvement in the survival of the HIV population has occurred with the ascendance of highly active antiretroviral therapy (HAART). In the foreseeable future, HIV-infected women who acquired disease during the peak years of the epidemic are expected to survive to experience menopause and even years beyond. The HIV epidemic may be viewed as 'mature', as its earlier victims become part of the geriatric population. Research about the process of menopause in HIV-infected women and, conversely, about HIV infection in women undergoing menopause is currently limited. Existing research suggests that the process of menopause is affected by HIV infection, inasmuch as infected women appear to experience menopause at an earlier age, with greater symptomatology, and with different reproductive hormone profiles compared with HIV-uninfected women. HIV infection also appears to affect bone mineral density, cardiovascular disease and cognition, with some age-related interactions. Lifestyle and demographic factors have pervasive importance for both HIV infection and the menopause in women. This article reviews the current state of knowledge about the menopausal process in HIV-infected women, and the common conditions in postmenopausal women that are likely to be affected by HIV infection. Clinicians should appreciate the potential role of HIV infection in caring for menopause-aged women.",
keywords = "Bone density, Cardiovascular diseases, Cognition, HIV, Menopause",
author = "Fan, {Maria D.} and Maslow, {Bat Sheva} and Nanette Santoro and Ellie Schoenbaum",
year = "2008",
month = "12",
doi = "10.1258/mi.2008.008027",
language = "English (US)",
volume = "14",
pages = "163--168",
journal = "Post reproductive health",
issn = "2053-3691",
publisher = "Sage Publications",
number = "4",

}

TY - JOUR

T1 - HIV and the menopause

AU - Fan, Maria D.

AU - Maslow, Bat Sheva

AU - Santoro, Nanette

AU - Schoenbaum, Ellie

PY - 2008/12

Y1 - 2008/12

N2 - Dramatic improvement in the survival of the HIV population has occurred with the ascendance of highly active antiretroviral therapy (HAART). In the foreseeable future, HIV-infected women who acquired disease during the peak years of the epidemic are expected to survive to experience menopause and even years beyond. The HIV epidemic may be viewed as 'mature', as its earlier victims become part of the geriatric population. Research about the process of menopause in HIV-infected women and, conversely, about HIV infection in women undergoing menopause is currently limited. Existing research suggests that the process of menopause is affected by HIV infection, inasmuch as infected women appear to experience menopause at an earlier age, with greater symptomatology, and with different reproductive hormone profiles compared with HIV-uninfected women. HIV infection also appears to affect bone mineral density, cardiovascular disease and cognition, with some age-related interactions. Lifestyle and demographic factors have pervasive importance for both HIV infection and the menopause in women. This article reviews the current state of knowledge about the menopausal process in HIV-infected women, and the common conditions in postmenopausal women that are likely to be affected by HIV infection. Clinicians should appreciate the potential role of HIV infection in caring for menopause-aged women.

AB - Dramatic improvement in the survival of the HIV population has occurred with the ascendance of highly active antiretroviral therapy (HAART). In the foreseeable future, HIV-infected women who acquired disease during the peak years of the epidemic are expected to survive to experience menopause and even years beyond. The HIV epidemic may be viewed as 'mature', as its earlier victims become part of the geriatric population. Research about the process of menopause in HIV-infected women and, conversely, about HIV infection in women undergoing menopause is currently limited. Existing research suggests that the process of menopause is affected by HIV infection, inasmuch as infected women appear to experience menopause at an earlier age, with greater symptomatology, and with different reproductive hormone profiles compared with HIV-uninfected women. HIV infection also appears to affect bone mineral density, cardiovascular disease and cognition, with some age-related interactions. Lifestyle and demographic factors have pervasive importance for both HIV infection and the menopause in women. This article reviews the current state of knowledge about the menopausal process in HIV-infected women, and the common conditions in postmenopausal women that are likely to be affected by HIV infection. Clinicians should appreciate the potential role of HIV infection in caring for menopause-aged women.

KW - Bone density

KW - Cardiovascular diseases

KW - Cognition

KW - HIV

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=61549108664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61549108664&partnerID=8YFLogxK

U2 - 10.1258/mi.2008.008027

DO - 10.1258/mi.2008.008027

M3 - Article

C2 - 19037065

AN - SCOPUS:61549108664

VL - 14

SP - 163

EP - 168

JO - Post reproductive health

JF - Post reproductive health

SN - 2053-3691

IS - 4

ER -